RecruitingPhase 1NCT06792344

Clinical Study of CD19 CAR-T in the Treatment of Refractory Systemic Sclerosis

Studying Systemic sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
The Children's Hospital of Zhejiang University School of Medicine
Intervention
anti-CD19 CAR-T cells(other)
Enrollment
12 enrolled
Eligibility
5-18 years · All sexes
Timeline
20242027

Study locations (2)

Collaborators

Guangzhou Women and Children's Medical Center

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06792344 on ClinicalTrials.gov

Other trials for Systemic sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Systemic sclerosis

← Back to all trials